| Title |
Myco-protein from Fusarium venenatum: a well-established product for human consumption
|
|---|---|
| Published in |
Applied Microbiology and Biotechnology, February 2002
|
| DOI | 10.1007/s00253-002-0931-x |
| Pubmed ID | |
| Authors |
M. Wiebe |
| Abstract |
Fusarium venenatum A3/5 was first chosen for development as a myco-protein in the late 1960s. It was intended as a protein source for humans and after 12 years of intensive testing, F. venenatum A3/5 was approved for sale as food by the Ministry of Agriculture, Fisheries and Food in the United Kingdom in 1984. Today, myco-protein is produced in two 150,000 l pressure-cycle fermenters in a continuous process which outputs around 300 kg biomass/h. The continuous process is typically operated for around 1,000 h. One factor which has limited the length of production runs was the appearance of highly branched mutants in the population. Several factors affect the time of appearance of such mutants and a number of strategies for delaying their appearance have been investigated. After reduction of the RNA content, the fungal biomass is mixed with egg albumin and made into a variety of products. Consumption of these can lead to reduced blood cholesterol and to lower energy intake in a subsequent meal. E venenatum myco-protein is now used in products available in six European countries and there are plans for it to be sold in France, the United States and Germany. |
Mendeley readers
The data shown below were compiled from readership statistics for 424 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Slovakia | 2 | <1% |
| India | 1 | <1% |
| Portugal | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 419 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 63 | 15% |
| Student > Master | 60 | 14% |
| Student > Bachelor | 59 | 14% |
| Student > Ph. D. Student | 41 | 10% |
| Other | 16 | 4% |
| Other | 57 | 13% |
| Unknown | 128 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 103 | 24% |
| Biochemistry, Genetics and Molecular Biology | 65 | 15% |
| Engineering | 24 | 6% |
| Chemical Engineering | 17 | 4% |
| Chemistry | 13 | 3% |
| Other | 54 | 13% |
| Unknown | 148 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2024.
All research outputs
#1,593,875
of 25,371,288 outputs
Outputs from Applied Microbiology and Biotechnology
#99
of 8,290 outputs
Outputs of similar age
#2,408
of 126,864 outputs
Outputs of similar age from Applied Microbiology and Biotechnology
#1
of 47 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,290 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.